Medigene ()【MDGEF】銘柄情報

Medigene AG () (MDGEF) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.10

( - )

買値

0.00

売値

0.00

出来高

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

1.489M

前日終値

0.10

始値

時刻

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

US$ 5,891

発行済株式数

14,887,594

配当利回り

PER

-0.01

1 株当たり利益 (EPS)

-1.26

歳入

7.45M

純利益

-15.93M

Medigene AG is in the process of liquidation of its remaining assets. Previously, the company was engaged in the development of T-cell therapies for the treatment of cancer. Medigene AG was founded in 1994 and is headquartered in Munich, Germany. Medigene AG is in the process of liquidation of its remaining assets. Previously, the company was engaged in the development of T-cell therapies for the treatment of cancer. Medigene AG was founded in 1994 and is headquartered in Munich, Germany.

セクター

Finance

業界

Asset Management Services

ウェブサイト

www.medigene.com

本社

Munich, Germany

設立

1994

Medigene AG () is listed in the Finance sector of the その他OTC with ticker MDGEF. The last closing price for Medigene () was US$0.10. Over the last year, Medigene () shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Medigene () currently has 14,887,594 shares in issue. The market capitalisation of Medigene () is US$1.49 million. Medigene () has a price to earnings ratio (PE ratio) of -0.01.

Deleted Symbol

Thu, Sep 05, 2013 12:00 - MediGene AG (MDGEF: Grey Market) - Deleted Symbol - As of Thu, Sep 05, 2013, MDGEF is no longer a valid symbol. You may...

Annual Result 2005 and Forecast 2006 of MediGene AG: Significant Increase in Revenues and Improved Result

* Total revenues increased by 50% to 19.7 million euro (2004: 13.1 million euro) * Operating loss (EBIT) reduced by 22% to -11.5 million euro...

MediGene AG Decides to Raise EUR 15.6 MM in a Share Capital Increase

MARTINSRIED, Germany and SAN DIEGO, March 2 /PRNewswire-FirstCall/ -- The Executive Board of the German-American biotech company MediGene AG...

MediGene's Prostate Cancer Drug* Launched in France and Other European Countries

- MediGene Receives Milestone Payment for Launch in France - MediGene's First Drug* Now Available in 11 European Countries MARTINSRIED, Germany...

MediGene to Present at BIO CEO & Investor Conference in New York City

MARTINSRIED/MUNICH, Germany and SAN DIEGO, Feb. 14 /PRNewswire-FirstCall/ -- The German-American biotech company MediGene AG (German Stock...

MediGene and Bradley Pharmaceuticals Enter Marketing and Development Partnership for Polyphenon(R) E Ointment

* Bradley acquires US commercialization rights for genital warts and other dermatological diseases. MediGene retains full rest of world...

MediGene Receives One-Time Payment for License Agreement with Glaxo Group

* A non-exclusive license under existing tumor-vaccine patents MARTINSRIED, Germany and MUNICH, Germany, and SAN DIEGO, Dec. 19...

MediGene Announces FDA Acceptance of New Drug Application for Polyphenon(R) E* Ointment for the Treatment of Genital Warts

MARTINSRIED and MUNICH, Germany and SAN DIEGO, Dec. 1 /PRNewswire-FirstCall/ -- The German-American biotech company MediGene AG (Frankfurt...

MediGene AG Announces Nine-Months Result and Confirms Forecast for the Year

* Total revenues of 8.6 million euro (9M-2004: 11.5 million euro) MARTINSRIED/MUNICH, Germany and SAN DIEGO, Nov. 2 /PRNewswire-FirstCall/...

MediGene AG Initiates Clinical Phase II - Trial of EndoTAG(TM)-1* in Advanced Pancreatic Cancer

MARTINSRIED, Germany and SAN DIEGO, Aug. 24 /PRNewswire-FirstCall/ -- Today the German-American biotech company MediGene AG (Frankfurt, Prime...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

MDGEF - Frequently Asked Questions (FAQ)

What is the current Medigene AG () share price?

The current share price of Medigene AG () is US$ 0.10

How many Medigene AG () shares are in issue?

Medigene AG () has 14,887,594 shares in issue

What is the market cap of Medigene AG ()?

The market capitalisation of Medigene AG () is USD 1.49M

What is the 1 year trading range for Medigene AG () share price?

Medigene AG () has traded in the range of US$ 0.00 to US$ 0.00 during the past year

What is the PE ratio of Medigene AG ()?

The price to earnings ratio of Medigene AG () is -0.01

What is the cash to sales ratio of Medigene AG ()?

The cash to sales ratio of Medigene AG () is 0.03

What is the registered address of Medigene AG ()?

The registered address for Medigene AG () is Lochhamer Strasse 11, Munich, Bavaria, 82152

What is the Medigene AG () website address?

The website address for Medigene AG () is www.medigene.com

Which industry sector does Medigene AG () operate in?

Medigene AG () operates in the Asset Management Services sector

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Medigene AG () (MDGEF)

Medigene AG () (MDGEF) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

Medigene AG () について

MDGEF 最新ニュース

Deleted Symbol

Annual Result 2005 and Forecast 2006 of MediGene AG: Significant Increase in Revenues and Improved Result

MediGene AG Decides to Raise EUR 15.6 MM in a Share Capital Increase

MediGene's Prostate Cancer Drug* Launched in France and Other European Countries

MediGene to Present at BIO CEO & Investor Conference in New York City

MediGene and Bradley Pharmaceuticals Enter Marketing and Development Partnership for Polyphenon(R) E Ointment

MediGene Receives One-Time Payment for License Agreement with Glaxo Group

MediGene Announces FDA Acceptance of New Drug Application for Polyphenon(R) E* Ointment for the Treatment of Genital Warts

MediGene AG Announces Nine-Months Result and Confirms Forecast for the Year

MediGene AG Initiates Clinical Phase II - Trial of EndoTAG(TM)-1* in Advanced Pancreatic Cancer

MDGEF - Frequently Asked Questions (FAQ)

MDGEF 取引

議論

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Medigene AG () (MDGEF)

Medigene AG () (MDGEF) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

Medigene AG () について

MDGEF 最新ニュース

Deleted Symbol

Annual Result 2005 and Forecast 2006 of MediGene AG: Significant Increase in Revenues and Improved Result

MediGene AG Decides to Raise EUR 15.6 MM in a Share Capital Increase

MediGene's Prostate Cancer Drug* Launched in France and Other European Countries

MediGene to Present at BIO CEO & Investor Conference in New York City

MediGene and Bradley Pharmaceuticals Enter Marketing and Development Partnership for Polyphenon(R) E Ointment

MediGene Receives One-Time Payment for License Agreement with Glaxo Group

MediGene Announces FDA Acceptance of New Drug Application for Polyphenon(R) E* Ointment for the Treatment of Genital Warts

MediGene AG Announces Nine-Months Result and Confirms Forecast for the Year

MediGene AG Initiates Clinical Phase II - Trial of EndoTAG(TM)-1* in Advanced Pancreatic Cancer

MDGEF - Frequently Asked Questions (FAQ)

MDGEF 取引

議論

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

ADVFNに参加する理由

プロトレーダー向けの高機能ツール

広告を削除する

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS